Related Experiment Videos

Breast Cancer: High-Dose Therapy.

Subramanyan1, Kennedy

  • 1Johns Hopkins Oncology Center, Baltimore, Maryland, 21287, USA. ssubrama@welchlink.welch.jhu.edu

The Oncologist
|July 1, 1999
PubMed
Summary

High-dose chemotherapy with autologous stem cell rescue (HDC/ASCR) for breast cancer shows promise but may be influenced by selection bias in non-randomized studies. Clinical trials are essential to confirm its efficacy and determine its future role.

Related Concept Videos